Advantis Corp
OTC:ADVT
Advantis Corp?
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Advantis Corp hold over its rivals?
What risks and challenges
does Advantis Corp face in the near future?
Provide an overview of the primary business activities
of Advantis Corp.
Compare the intrinsic valuations
of Advantis Corp and its key competitors using the latest financial data.
Provide an overview of the primary business activities
of Advantis Corp.
What unique competitive advantages
does Advantis Corp hold over its rivals?
What risks and challenges
does Advantis Corp face in the near future?
Compare the intrinsic valuations
of Advantis Corp and its key competitors using the latest financial data.
Relative Value
There is not enough data to reliably calculate the relative value of ADVT.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ADVT Competitors Multiples
Advantis Corp Competitors
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
A
|
Advantis Corp
OTC:ADVT
|
978.5 USD | 0 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
695.1B USD | 50.4 |
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | -15 783.5 |
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
425.3B USD | 18.8 |
|
| CH |
|
Roche Holding AG
SIX:ROG
|
208.9B CHF | 25.2 |
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.2B GBP | 29.9 |
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK | 14.3 |
|
| CH |
|
Novartis AG
SIX:NOVN
|
197.4B CHF | 18 |
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
211.5B USD | 12.9 |
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
195.2B USD | -66.8 |
|
| US |
|
Pfizer Inc
NYSE:PFE
|
142.5B USD | 13.3 |
|
| Earnings Growth | PEG | |||||
|---|---|---|---|---|---|---|
| US |
A
|
Advantis Corp
OTC:ADVT
|
Average P/E:
22.8
|
N/A | N/A | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
50.4
|
50%
|
1 |
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Negative Multiple: -15 783.5 | N/A | N/A |
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
18.8
|
28%
|
0.7 |
|
| CH |
|
Roche Holding AG
SIX:ROG
|
25.2
|
29%
|
0.9 |
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
29.9
|
37%
|
0.8 |
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
14.3
|
10%
|
1.4 |
|
| CH |
|
Novartis AG
SIX:NOVN
|
18
|
18%
|
1 |
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
12.9
|
16%
|
0.8 |
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
Negative Multiple: -66.8 | N/A | N/A |
|
| US |
|
Pfizer Inc
NYSE:PFE
|
13.3
|
30%
|
0.4 |
|
You don't have any saved screeners yet
